A cell culture is basically keeping the cells taken out of a source in an artificial environment alive. Various instruments that are used for cell and tissue culturing are plates, flasks, culture bags, pipetting instruments, incubators, cryostorage equipment, biosafety cabinets, and others.The global cell and tissue culture supplies market is estimated to account for US$ 53,065.9 Mn in terms of value by the end of 2027

Browse Summary of the Research Report- https://www.coherentmarketinsights.com/market-insight/cell-and-tissue-culture-supplies-market-3770

Increasing R&D in the field of cell and tissue engineering is expected to propel growth of the global cell and tissue culture supplies market over the forecast period. For instance, in March 2020, researchers from Seoul National University, Korea, reported a method to model biomechanical-stimuli-induced blood vessel compression in vitro within a polydimethylsiloxane microfluidic 3D microvascular tissue culture platform with an integrated pneumatically actuated compression mechanism.

Moreover, increasing prevalence of chronic diseases is also expected to aid in growth of the market. For instance, according to the study, “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition”, published in the journal Diabetes Research and Clinical Practice, in September 2019, 463 million people are expected to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045.

XX held dominant position in the global cell and tissue culture supplies market in 2019, accounting for 49.5% share in terms of value, followed by Europe and Asia Pacific, respectively

Strangest license and accreditation procedures are expected to hinder growth of the market. Stringent license and accreditation procedures involved with maintaining cell and tissue cultures allow only specific companies to operate in the market. Several associations such as the American Association of Blood Banks (AABB), the Foundation for the Accreditation of Cellular Therapy (FACT), the Human Tissue Authority (HTA), and the Joint Accreditation Committee - ISCT (Europe) & EBMT (JACIE) are involved in licensure and accreditation procedures.

Moreover, complexity in cell culture techniques is also expected to limit growth of the market. In cell culturing, there are certain steps that require a specific environment in order to be successful. Any alteration in the environment would lead to changes in the characteristics of the cell culture, which in turn would increase the risk of observing different features in the products prepared by a technique.

The consumables products segment in the global cell and tissue culture supplies market was valued at US$ 11,625.2 Mn in 2019 and is forecast to reach a value of US$ 25,278.6 Mn by 2027 at a CAGR of 10.2% between 2017 and 2027

Market Trends/Key Takeaways

Contract manufacturing or contract research is gaining popularity in the field of cell and tissue culturing. Various leading pharmaceutical companies, which lag in potential and skilled professionals, are giving contracts to other companies for research in cell and tissue culture. This is expected to drive the market growth.

Market shift towards serum-free media and animal-derived component-free (ADFC) media has been observed. Various manufacturers present in the market have started supplying serum-free media owing to advantages such as specificity in terms of nutrients and lower risk of infection. Though, serum-free media is costlier than serum media, benefits of the former compensate for the price in the long term. Disadvantages of serum media include, no defined composition, variation in the results obtained, risk of infections, and reduced specificity, among others.

Major players operating in the global cell and tissue culture supplies market include, Becton, Dickinson and Company, Merck KGaA, Corning, Inc., Lonza Group, Eppendorf AG, Thermo Fisher Scientific, Inc., Affymetrix, Inc., GE Healthcare, VWR International, LLC, and WHEATON Industries, Inc.

Global Cell and Tissue Culture Supplies Market: Key Developments

Major players in the market are focused on product launch to expand their product portfolio. For instance, in February 2020, Eppendorf launched SciVario, its latest bioreactor control system for small- and bench-scale applications.

In October 2019, Thermo Fisher Scientific launched Gibco BenchStable Media in its Gibco product line. The new cell culture media remain stable at room temperature.

Request A Sample Copy - https://www.coherentmarketinsights.com/insight/request-sample/3770

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
*****************************************************************************